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ttp://dx.doi.org/10.1016/j.ajpath.2013.08.011Autophagy is a lysosomal degradation process that degrades long-lived cellular proteins and damaged
organelles as a critical cell survival mechanism in response to stress. We recently reported that acute
ethanol induces autophagy, which then reduces ethanol-induced liver injury. However, the mechanisms
by which ethanol induces autophagy are not known. In the present study, ethanol treatment signiﬁcantly
increased both mRNA and protein levels of various essential autophagy-related genes in primary cultured
mouse hepatocytes and in mouse liver. Both nuclear translocation of FoxO3a and expression of FoxO3a
target genes were increased in ethanol-treated primary hepatocytes and mouse liver. Overexpression of a
dominant negative form of FoxO3a inhibited ethanol-induced autophagy-related gene expression and
enhanced ethanol-induced cell death in primary hepatocytes, which suggests that FoxO3a is a key factor
in regulating ethanol-induced autophagy and cell survival. Resveratrol, a well-known SIRT1 agonist,
further enhanced ethanol-induced expression of autophagy-related genes, likely via increased deacety-
lation of FoxO3a. Moreover, acute ethanoletreated Foxo3a/ mice exhibited decreased autophagy-
related gene expression, but enhanced steatosis and liver injury, compared with wild-type mice.
FoxO3a thus plays a critical role in ethanol-induced autophagy in mouse liver. Modulating the FoxO3a
autophagy pathway may offer novel therapeutic approaches for treating alcoholic liver pathogenesis.
(Am J Pathol 2013, 183: 1815e1825; http://dx.doi.org/10.1016/j.ajpath.2013.08.011)Supported in part by NIH grants R01-AA020518-01 and P20-RR021940
(W.X.D), R01-AA015951 and R01-AA013623 (M.Y.), and P20-
GM103549 (COBRE grant to the University of Kansas Medical Center
Cell Isolation Core laboratory).Macroautophagy (hereafter referred to simply as autophagy)
is a bulk intracellular degradation system that is mainly
responsible for the degradation of long-lived proteins to
provide nutrients for survival in response to starvation.1,2
Accumulating evidence indicates that autophagy can also
selectively remove damaged or excess organelles, including
mitochondria, endoplasmic reticulum, ribosome, and per-
oxisome.3e5 In the liver, autophagy can also help to remove
excess lipid droplets to attenuate steatosis (in which case it
is termed lipophagy).6
Alcoholic liver disease is a major disease of the liver in
Western countries and worldwide. The clinical characteristic
of this disease is the accumulation of excess fat in the liver in
response to alcohol consumption. In humans, it is known that
accumulation of excess fat can progress to more detrimental
forms of liver injury, such as inﬂammation, ﬁbrosis, and
cirrhosis. However, it is also well known that only a small
portion of alcohol drinkers can develop advanced liver
inﬂammation and ﬁbrosis, suggesting that a cellular protectivestigative Pathology.
.mechanism or mechanisms could play a critical role in miti-
gating alcohol-induced liver injury.7,8 Our research group
recently demonstrated that acute ethanol treatment induces
autophagy in primary cultured mouse hepatocytes and in
mouse liver; pharmacological induction of autophagy attenu-
ated and pharmacological inhibition of autophagy exacerbated
ethanol-induced steatosis and liver injury in mice.9 However,
the mechanisms by which acute ethanol induces autophagy in
hepatocytes are not known.
FoxO3a is a member of the FoxO (forkhead box O)
family of transcription factors. FoxO3a regulates expression
of genes involved in multiple cellular functions, including
oxidative stress, apoptosis, and cell-cycle transition, as well
as DNA repair.10,11 Recent evidence suggests that FoxO3a
Ni et alalso regulates expression of autophagy-related (Atg) genes
in mouse skeletal muscle12,13 and cardiomyocytes, which
promotes cardiomyocyte survival on induction of oxidative
stress.14
FoxO3a is regulated by multiple post-translational modi-
ﬁcations, including phosphorylation, acetylation, and ubiq-
uitination.10,11 FoxO3a is phosphorylated by the serine/
threonine protein kinase Akt and becomes sequestered in the
cytoplasm, where it is unable to regulate gene expression. In
contrast, SIRT1 [sirtuin (silent mating type information
regulation 2 homolog) 1 (S. cerevisiae)] deacetylates FoxO3a
and modulates its gene transcription and speciﬁcity, which
increases antioxidative stress genes and suppresses apoptosis
genes in response to oxidative stress.10,15 However, it is not
known whether acetylation of FoxO3a affects expression of
autophagy-related genes.
In the present study, we demonstrated that acute ethanol
treatment activates FoxO3a in mouse liver and in primary
cultured mouse hepatocytes. The increased nuclear retention
of FoxO3a by ethanol could be mediated by decreased Akt
activity.Genetic inhibitionof FoxO3a led to the suppression of
ethanol-induced expression of autophagy-related genes and
exacerbated ethanol-induced liver injury in mice. Moreover,
we also found increased autophagy-related gene expression
and autophagic ﬂux in ethanol-treated human hepatocytes.
Materials and Methods
Reagents
The following antibodieswere used:Atg5 (PM050) fromMBL
International (Woburn, MA); Beclin 1 (sc11427) and ULK1
(sc33182) from Santa Cruz Biotechnology (Santa Cruz, CA);
Bnip3 (Ab10433) andNix (Ab8399) fromAbcam (Cambridge,
MA); p62 (H00008878-M01) from Abnova (Walnut, CA);
Atg7 (2631), p-FoxO3aS253 (9466), FoxO3a (2497), p-AktS473
(4060), Akt (2966), Sirt1 (2028), antieacetylated-lysine
(9441), and Lamin A/C (2032) from Cell Signaling Technol-
ogy (Danvers, MA); and b-actin (A5441) and Atg14 (A6358)
from Sigma-Aldrich (St. Louis, MO). Horseradish perox-
idaseeconjugated or Cy3-conjugated secondary antibodies
were from Jackson ImmunoResearch Laboratories (West
Grove, PA). Rabbit polyclonal anti-LC3B antibody was
generated as described previously.9 Adenovirus GFP-LC3
(Ad-GFP-LC3), Ad-GFP, and adenovirus-dominant negative
FoxO3a (Ad-DN-Foxo3a) were generated as described previ-
ously.12,16 Chloroquine (CQ), rapamycin, actinomycin D
(ActD), and resveratrol were fromSigma-Aldrich. Ethanolwas
from Pharmco (Brookﬁeld, CT), and all other chemicals were
from Sigma-Aldrich, Life Technologies (Carlsbad, CA), or
Calbiochem (EMDMillipore, Billerica, MA).
Animals
Wild-type C57BL/6 mice were purchased from the Jackson
Laboratory (BarHarbor,ME).Foxo3a/micewere generated1816as described previously.17 Cryopreserved Foxo3aþ/ mouse
embryoswere purchased from theRIKENBioResourceCenter
(Ibaraki, Japan) and recovered at the Animal Transgenic Core
facility at the University of Kansas Medical Center. The
Foxo3aþ/ mice were maintained in a B6;129 background.
Female Foxo3a/ mice are infertile; Foxo3a/ mice were
therefore generated by crossing male Foxo3aþ/ with female
Foxo3aþ/mice. The generatedFoxo3aþ/þmice were used as
wild-type controls.
All animals received humane care according to the
guidelines of the NIH and the University of Kansas Medical
Center.
Mouse Ethanol Binge Treatment
Mouse ethanol treatment was modiﬁed from the model of
Carson and Pruett,18 as we have described previously.9 This
modelwas designed to achieve blood alcohol levels, behavioral
effects, and physiological effects comparable to those ofhuman
binge drinking. After 6 hours of fasting, male Foxo3a/mice
and their wild-type littermates were administered 33% (v/v)
ethanol at a total cumulative dose of 4.5 g/kg body weight by
four equally divided gavages at 15-minute intervals. Control
mice received the same volume of double-distilledwater. After
6, 12, and 16 hours of treatment, the mice were sacriﬁced, and
blood samples and liver tissueswere collected.Liver injurywas
assessed by determination of serum alanine aminotransferase
activity and H&E staining of liver sections, as we have de-
scribed previously.19 Total liver lysates were prepared using
radioimmunoprecipitation assay buffer [1% NP40, 0.5% so-
dium deoxycholate, 0.1% sodium dodecyl (lauryl) sulfate].
Primary Hepatocyte Culture
Mouse hepatocytes were isolated by a retrograde, nonre-
circulating perfusion of livers with 0.05% collagenase type IV
(Sigma-Aldrich), as we have described previously.20 Cells
were cultured in Williams’ medium E with 10% fetal bovine
serum, but no other supplements, for 2 hours to allow for
attachment. Human hepatocytes were isolated and cultured
according to methods described previously by Gramignoli
et al.20 All cells were maintained in a 37C incubator with 5%
CO2. All human liver specimens were obtained in accordance
with the protocol (no. 13513) approved by the University
of Kansas Medical Center Human Subjects Committee.
Immunoblot Assay
Cells were washed in PBS and lysed in radioimmunopre-
cipitation assay buffer. From each sample, 20mg of proteinwas
separated by SDS-PAGE and transferred to polyvinylidene
diﬂuoride membranes. The membranes were immunoblotted
with primary antibodies, followed by secondary horseradish
peroxidase-conjugated antibodies. The membranes were
further developed with Pierce SuperSignal West Pico chemi-
luminescent substrate (Thermo Fisher Scientiﬁc, Rockford,ajp.amjpathol.org - The American Journal of Pathology
FoxO3a in Alcohol-Induced AutophagyIL). Densitometry analysis was performed using Un-Scan-It
software version 6.1 (Silk Scientiﬁc, Orem,UT).Densitometry
data were further normalized with either b-actin or the
respective total protein and expressed as means  SEM.
qPCR
RNAwas isolated frommouse livers usingTRIzol reagent (Life
Technologies) and was reverse-transcribed into cDNA with
Fermentas RevertAid Reverse Transcriptase (Thermo Fisher
Scientiﬁc, Waltham, MA). Quantitative real-time PCR (qPCR)
to quantify gene expression of Atg5, Beclin 1 (Becn1; alias
Atg6), Atg7, microtubule-associated protein 1 light chain 3
beta (Map1lc3b; alias LC3b), Ulk1, BCL2/adenovirus E1B
interacting protein 3 (Bnip3), and b-actin (Actb) was per-
formed on an ABI Prism 7900HT real-time PCR instrument
(Life Technologies) using Fermentas Maxima SYBR Green/
ROX qPCR reagents (Thermo Fisher Scientiﬁc). The forward








30 and 50-ACACTTCGGAGATGGGAGTG-30; ULK1, 50-
GGTGGAGACCTGGCTGACTA-30 and 50-TCTTGACTC-
GGATGTTGCTG-30; and Bnip3, 50-AGCTTTGGCGAGA-
AAAACAG-30 and 50-TCCAATGTAGATCCCCAAGC-30.
Microscopy for Autophagy and Cell Death
To examine autophagy, primary mouse hepatocytes were
seeded in a 12-well plate (2 105 cells per well) and infected
overnightwithAd-GFP-LC3 (100viral particles per cell).Cells
were treatedwith 80mmol/L ethanol in the presence or absence
of 0.1 mg/mL ActD or with 50 mmol/L resveratrol for 6 hours.
After treatment, cells were ﬁxed with 4% paraformaldehyde in
PBS for 2 hours at room temperature or were kept at 4C for
microscopy. Fluorescence images were acquired under an
Eclipse 200 ﬂuorescence microscope (Nikon, Tokyo, Japan)
with MetaMorph software version 6.1 (Downingtown, PA).
For the immunostaining assay, ﬁxed primary hepatocytes or
cryosections of liver tissues were immunostained with anti-
FoxO3a antibody followed by Cy3-conjugated secondary
antibody and Hoechst 33342 nuclear staining, as described
previously.21 Cell death and morphological changes were
analyzed with 1 mg/mL Hoechst 33342 staining and ﬂuores-
cence imaging. All images were obtained using digital ﬂuo-
rescence microscopy as described above.
Nuclear Fractionation
Mouse liver nuclear proteins were extracted using Pierce
NE-PER nuclear and cytoplasmic extraction reagentsThe American Journal of Pathology - ajp.amjpathol.org(Thermo Fisher Scientiﬁc) according to the manufacturer’s
instructions. In brief, liver tissues were cut into small pieces,
homogenized in cytoplasmic extraction reagent I with sub-
sequent addition of cytoplasmic extraction reagent II, and
centrifuged. The supernatants resulting from centrifugation
were cytoplasmic fractions. The insoluble pellets were
suspended in nuclear extraction reagent and centrifuged; the
supernatants resulting from this centrifugation contained
nuclear proteins.
Hepatic Triglyceride Analysis
Triglyceride level was determined as described previously.9
Frozen liver tissues (50 to 100 mg) were ground using a
mortar and pestle. The crushed liver tissues were further
incubated with 1 mL of a chloroform/methanol (2:1) mix
with vigorous shaking for 1 hour at room temperature. Then,
200 mL of double-distilled water was added into the mix and
centrifuged for 5 minutes at 3000  g. The lower lipid phase
was collected and dried at room temperature, and the pellet
was redissolved in a tert-butanol and Triton X-114/meth-
anol (2:1) mix. Triglyceride analysis was performed with a
colorimetric assay kit according to the manufacturer’s in-
structions (Sigma-Aldrich).
Statistical Analysis
Experimental data were subjected to a Student’s t-test or one-
way analysis of variance analysis with Scheffé’s post hoc test
where appropriate. P < 0.05 was considered signiﬁcant.
Results
Acute Ethanol Treatment Increases the Expression of
Autophagy Genes in Mouse Liver and in Primary
Cultured Mouse Hepatocytes
To investigate the expression of autophagy-related genes in
mouse liver, male wild-type C57BL/6 mice were adminis-
tered 4.5 g/kg of water or ethanol for 6, 12, and 16 hours. This
animal model, initially established by Carson and Pruett,18
has been widely used to mimic human binge drinking and
acute alcohol abuse.22,23 In this model, an ethanol dose of 4 to
6 g/kg via gavage resulted in a peak blood ethanol concen-
tration of 43.4 to 86.8 mmol/L, which can be commonly
achieved in human binge drinkers.22 Using this acute alcohol
gavage model, we found that the mRNA levels of various
autophagy-related genes, including Ulk1 (yeast Atg1), Atg5,
Becn1 (yeast Atg6), Atg7, LC3b (yeast Atg8), Atg14, and
Pik3c3 (alias Vps34) were all increased in ethanol-treated
mouse liver at all time points. Expression levels of most
genes that we assessed (Ulk1, Becn1, LC3b, Atg14, and
Vps34) peaked after 6 hours of treatment with ethanol
(Figure 1A). Expression levels of these autophagy-related
genes started to decrease after 12 and 16 hours of treatment
with ethanol, but were still signiﬁcantly higher than in1817
Figure 1 Acute ethanol treatment increases
the expression of autophagy-related genes in
mouse liver and primary hepatocytes. A: Male
C57BL/6 mice were treated with 4.5 g/kg water or
ethanol by gavage for 6, 12, or 16 hours. Hepatic
mRNA was isolated, and RT-qPCR was performed.
B: Mice were treated as for A, and total liver ly-
sates were subjected to Western blot analysis,
followed by densitometry analysis. C: Primary
cultured mouse hepatocytes were treated with 80
mmol/L ethanol for 3, 6, 9, and 16 hours. mRNA
was isolated from cultured hepatocytes, and RT-
qPCR was performed. D: Primary cultured mouse
hepatocytes were treated as for C, and total
cell lysates were subjected to Western blot anal-
ysis, followed by densitometry analysis. Data are
presented as means  SEM (fold of control).
n Z 4e6 (A); n Z 4 (B and C); nZ 3 (D). *P <
0.05, one-way analysis of variance with Scheffé’s
post hoc test.
Ni et alcontrols (Figure 1A). Consistent with increased mRNA
expression, ethanol treatment also increased Atg5, Beclin 1,
Atg7, and LC3B-II protein levels; however, the extent of
increase and the respective peak time varied. The expression
levels of some proteins (such as Atg5) increased approxi-
mately threefold, whereas expression levels of others (such as
Atg7 and Beclin 1) increased 60% to 80%, compared with
control (Figure 1, B and C). It seems that Atg5, Beclin 1, and
Atg14 were maintained at higher levels during the treatment,
whereas Atg7 and LC3B-II increased at 6 hours but then
slightly declined at 12 and 16 hours of ethanol treatment. We
have previously demonstrated an increase in autophagic ﬂux
induced by ethanol; in the presence of CQ, which blocks
lysosomal degradation, ethanol-induced LC3B-II levels were
further enhanced by CQ treatment.9 Therefore, the decreased
LC3B-II levels after prolonged ethanol treatment (12 and 16
hours) were likely due to autophagic degradation of LC3B-II.
Consistent with in vivo ﬁndings, we also found elevated
mRNA levels of several autophagy-related genes in ethanol-
treated primary mouse hepatocytes as early as 3 hours and
sustained to 16 hours (Figure 1C). Moreover, ethanol treat-
ment also increased Atg5, Beclin 1, Atg7, and LC3B-II
protein levels in a time-dependent manner (Figure 1D).
ActD Suppresses Ethanol-Induced Expression of
Autophagy-Related Proteins and GFP-LC3 Puncta
To further investigate the role of gene transcription in
ethanol-induced autophagy, we treated primary cultured
mouse hepatocytes with ethanol in the presence or absence
of ActD, a general transcription inhibitor. Beclin 1, Atg7,
Bnip3, and LC3B-II protein levels induced by ethanol
decreased in the presence of ActD (Figure 2A). Consistent1818with our previous reports,9 ethanol treatment increased the
number of GFP-LC3 puncta in primary cultured mouse
hepatocytes, and these puncta were signiﬁcantly diminished
by ActD (Figure 2, B and C). More importantly, ActD also
blocked ethanol-induced autophagic ﬂux, as demonstrated
by the decreased LC3B-II levels when cells were treated
with ethanol together with ActD and CQ, compared with the
cells treated with ethanol and CQ. Furthermore, ethanol
treatment also decreased levels of p62, an autophagic sub-
strate protein that is usually degraded by autophagy.
Ethanol-induced decrease of p62 was blocked by ActD,
indicating that ActD inhibited ethanol-induced autophagic
ﬂux in hepatocytes (Figure 2D). These results suggest that
ethanol-induced expression of autophagy-related genes
could play an important role in ethanol-induced autopha-
gosome formation and autophagic ﬂux.
Ethanol Activates FoxO3a Both in Vivo and in Vitro
During mouse muscle atrophy, FoxO3a is activated to pro-
mote autophagy by up-regulating autophagy-related genes,
including LC3b, Atg12, and Becn1.12 In the present study,
ethanol treatment increased Beclin 1, Atg7, Bnip3, and LC3B
protein levels, and expression of these proteins was sup-
pressed by ActD. We therefore investigated whether ethanol
also activates FoxO3a and in turn increases the transcription
of Atg genes in hepatocytes. FoxO3a signals were diffuse in
both cytosol and nucleus in the liver of control mice, but the
FoxO3a nuclear signal dramatically increased after ethanol
treatment, indicating that ethanol increased nuclear FoxO3a
retention in mouse liver (Figure 3A). Western blot analysis
using nuclear fractions showed that ethanol treatment
increased nuclear FoxO3a levels approximately twofoldajp.amjpathol.org - The American Journal of Pathology
Figure 2 ActD inhibits ethanol-induced auto-
phagy in primary mouse hepatocytes. A: Primary
cultured hepatocytes were treated with ethanol in
the presence or absence of ActD for 6 hours. Total
cell lysates were subjected to Western blot anal-
ysis, followed by densitometry analysis. B: Ad-GFP-
LC3einfected hepatocytes were treated as for A
and were examined with ﬂuorescence microscopy.
Original magniﬁcation, 60. C: GFP-LC3 puncta
were quantiﬁed for each experiment, with at least
30 cells counted in each experiment. D: Primary
hepatocytes were treated as for A, with or without
20 mmol/L CQ for 6 hours, followed by Western
blotting and densitometry analysis. Data are
expressed as means  SEM. nZ 3 (A and D); nZ 4
(C). **P < 0.01, one-way analysis of variance with
Scheffé’s post hoc test.
FoxO3a in Alcohol-Induced Autophagy(Figure 3B). Moreover, hepatic mRNA levels of three known
FoxO3a target genes [Bnip3, Bim (reclassiﬁed as Bcl2l11),
and manganese superoxide dismutase (Sod2; alias MnSOD)]
also increased in ethanol-treated mouse liver (Figure 3C).
Similar to the in vivo ﬁndings, ethanol treatment also sig-
niﬁcantly increased nuclear FoxO3a levels in primary
cultured mouse hepatocytes (Figure 3, D and E). In addition,
ethanol treatment also increased the expression of the known
FoxO3a target genes Bnip3, Bnip3L, and MnSOD in vitro
(Figure 3F). These ﬁndings indicate that ethanol activates
FoxO3a in mouse liver and in primary cultured mouse
hepatocytes.
Ethanol Induces Alterations of the Post-Translational
Modiﬁcations of FoxO3a in Mouse Liver
Because FoxO3a is regulated by multiple post-translational
modiﬁcations, including phosphorylation and acetylation,10
we next investigated whether ethanol treatment affects
phosphorylation and acetylation of FoxO3a. Compared with
control mice, ethanol treatment decreased the level of p-
FoxO3a in mouse liver (Figure 4A). These ﬁndings are
consistent with our immunostaining data and nuclear
Western blot analysis, showing that ethanol increased nu-
clear FoxO3a (Figure 3A), because p-FoxO3a is liable to be
exported to the cytosol from the nucleus. This decreased
phosphorylation of FoxO3a could be due to decreased Akt
phosphorylation, because Akt phosphorylates FoxOs to
promote their nuclear exportation.11 Indeed, the p-Akt levels
in ethanol-treated mouse livers were decreased, compared
with control (Figure 4A). In addition to phosphorylation, the
transcriptional activity of FoxO3a can also be regulated byThe American Journal of Pathology - ajp.amjpathol.orgSirt1-mediated deacetylation. Ethanol treatment decreased
hepatic Sirt1 (Figure 4B), which was correlated with
increased acetylated FoxO3a (Figure 4C). These data indi-
cate that acute ethanol treatment decreases the level of
phosphorylated FoxO3a, but increases acetylated FoxO3a;
the latter is likely associated with a decrease in hepatic Sirt1
induced by ethanol treatment.
Resveratrol Further Increases Ethanol-Induced
Autophagy Gene Expression by Decreasing FoxO3a
Acetylation
To investigate the inﬂuence of acetylation of FoxO3a on
ethanol-induced expression of autophagy-related genes, we
treated primary mouse hepatocytes with ethanol in the
presence or absence of resveratrol, a well-known Sirt1
agonist24 that decreases ethanol-induced liver injury.25 We
found that resveratrol alone slightly increased the mRNA
levels of Atg5, LC3b, and Vps34, but the combined treat-
ment of ethanol and resveratrol further increased ethanol-
induced expression of these autophagy-related genes
(Figure 5A). Ethanol-induced acetylation of FoxO3a was
suppressed by resveratrol (Figure 5B), suggesting that
deacetylated FoxO3a may further promote autophagy-
related gene transcription. More importantly, in the pres-
ence of resveratrol, the number of ethanol-induced GFP-LC3
puncta was further increased, suggesting that resveratrol
enhances ethanol-induced autophagosome formation
(Figure 5, C and D). These ﬁndings indicate that Sirt1-
mediated deacetylation of FoxO3a may promote expres-
sion of autophagy-related genes and autophagy induction
in ethanol-treated hepatocytes.1819
Figure 3 Ethanol activates FoxO3a inmouse liver and primary mouse hepatocytes.A: Male C57BL/6mice were treated with 4.5 g/kg water or ethanol by gavage for
16 hours. Cryosectioned liver tissue was subjected to immunostaining for FoxO3a using a rabbit anti-FoxO3a antibody, followed by a Cy3-conjugated goat anti-rabbit
antibody; nuclei were stained with Hoechst 33342. Representative ﬂuorescence microscopy images are shown.Boxed regions are shown at higher magniﬁcation at the
right. B: Mice were treated as for A, and nuclear fractions were isolated from control and ethanol-treated mouse liver, followed by Western blotting and densitometry
analysis. C: Hepatic mRNA was isolated, and RT-qPCR was performed. D: Primary cultured hepatocytes were treated with 80 mmol/L ethanol for 6 hours and ﬁxed in 4%
paraformaldehyde, then immunostained for FoxO3a as for A, and examined with ﬂuorescence microscopy. Representative images are shown. E: Cells with increased
nuclear FoxO3a staining were quantiﬁed for each experiment, with at least 100 cells counted in each experiment. F: mRNAs were isolated from cultured hepatocytes,
and RT-qPCR was performed. Data are presented as means  SEM. nZ 3 (A, B, D, E, and F); nZ 4e6 (C). *P < 0.05, Student’s t-test; **P < 0.01, Z-test.
Ni et alOverexpression of a DN-FoxO3a Suppresses Ethanol-
Induced Expression of Autophagy-Related Genes and
Enhances Ethanol-Induced Apoptosis in Hepatocytes
To determine whether overexpression of DN-FoxO3a sup-
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Figure 4 Ethanol induces post-translational modiﬁcation of FoxO3a in
mouse liver.A andB: C57BL/6micewere treated with 4.5 g/kg water or ethanol
by gavage for 16 hours. Total liver lysates were subjected to Western blot
analysis for phosphorylated and total FoxO3a and phosphorylated and total Akt
(A) and Sirt1 (B), followed by densitometry analysis. C: Mice were treated as for
A, and total liver lysates were immunoprecipitated with an anti-FoxO3a anti-
body, followed by Western blotting using an antieacetylated lysine antibody
and densitometry analysis. Data are expressed as means  SEM. nZ 4.
1820genes, we infected primary mouse hepatocytes with Ad-
GFP control and Ad-DN-FoxO3a, which also contains GFP
from a separate cytomegalovirus promoter.12 More than
80% of cells showed very high efﬁciency for the infection
after 24 hours of incubation (Figure 6A). After the cells were
further treated with ethanol for another 6 hours, ethanol-
induced expression of Becn1, Atg7, LC3b, and Atg12 was
inhibited by expression of DN-FoxO3a (Figure 6B).
Consistent with the changes at the mRNA level, the ethanol-
induced increases in Atg5 (Atg12) and Atg6 (Beclin 1)
protein levels were also inhibited by DN-FoxO3a
(Figure 6C). These results suggest that FoxO3a is respon-
sible for ethanol-induced expression of autophagy-related
genes. Furthermore, overexpression of DN-FoxO3a
inhibited ethanol-induced autophagic ﬂux in primary he-
patocytes (Figure 6D). Interestingly, we also found that CQ
treatment alone only mildly increased LC3B-II levels in
DN-FoxO3aeinfected cells (1.6 versus 1), suggesting that
DN-FoxO3a could also inhibit basal autophagy in hepato-
cytes (Figure 6D). We previously found that inhibition of
autophagy led to increased cell death and liver injury in
ethanol-treated primary hepatocytes and mice.9ajp.amjpathol.org - The American Journal of Pathology
Figure 5 Resveratrol enhances ethanol-induced expression of autophagy-
related genes. A: Primary cultured mouse hepatocytes were treated with
ethanol in the presence or absence of 50 mmol/L resveratrol (Res) for 6 hours.
mRNA was isolated from cultured hepatocytes before RT-qPCR was performed.
B: Total cell lysates were immunoprecipitated with an anti-FoxO3a antibody,
followed by Western blotting using an antieacetylated lysine antibody and
densitometry analysis. C: Ad-GFP-LC3einfected hepatocytes were treated as for
A and then were examined with ﬂuorescence microscopy. Representative GFP-
LC3 images are shown. Original magniﬁcation,60. D: The number of GFP-LC3
puncta per cell was quantiﬁed and twenty cells were counted in each experi-
ment. Data are expressed as means SEM. nZ 3 (A and B); nZ 4 (C and D).
*P < 0.05, one-way analysis of variance with Scheffé’s post hoc test.
FoxO3a in Alcohol-Induced AutophagyInterestingly, overexpression of DN-FoxO3a also enhanced
ethanol-induced apoptosis in primary mouse hepatocytes
(Figure 6E). Therefore, the increased cell death caused by
expression of DN-FoxO3a could be due to the inhibition ofFigure 6 Overexpression of DN-FoxO3a suppresses ethanol-induced expression
Representative ﬂuorescence images of primary cultured mouse hepatocytes, infec
contain a GFP using separate cytomegalovirus promoters for 24 hours. Original mag
80 mmol/L ethanol for 6 hours. mRNA was isolated from cultured hepatocytes, a
blotting and densitometry analysis. D: Primary hepatocytes were treated as in B,
Western blotting and densitometry analysis. E: Primary hepatocytes, infected as
stained with Hoechst 33342 for nuclei, and fragmented apoptotic nuclei were qu
analysis of variance with Scheffé’s post hoc test.
The American Journal of Pathology - ajp.amjpathol.orgethanol-induced expression of autophagy-related genes and
subsequent autophagy.
Ethanol-Induced Expression of Autophagy-Related
Genes Is Suppressed in Foxo3a/ Mice, Resulting in
Increased Liver Injury and Steatosis
To further investigate the role of FoxO3a in ethanol-induced
expression of autophagy-related genes and liver injury
in vivo, we treated Foxo3a/ and age-matched wild-type
mice with acute ethanol. Although the basal expression of
autophagy genes in Foxo3a/ mice did not differ sig-
niﬁcantly from that of wild-type mice, ethanol-induced
expression of autophagy-related genes was signiﬁcantly
suppressed in Foxo3a/ mice (Figure 7A). The expression
levels of several autophagy genes in ethanol-treated FoxO3a
wild-type mice (B6;129 background), such as Becn1 and
Atg7, were not induced as signiﬁcantly as in ethanol-treated
C57BL/6J wild-type mice (Figure 1A). These variations
could be due to the difference in genetic background.
Similar to ﬁndings at the mRNA level, several of the
ethanol-induced autophagy proteins were also suppressed in
Foxo3a/ mice (Figure 7D). More importantly, we further
found that serum alanine aminotransferase and hepatic tri-
glyceride levels were all signiﬁcantly increased in ethanol-
treated Foxo3a/ mice, compared with wild-type mice
(Figure 7, B and C). Notably, electron microscopy studies
revealed that the number of lipid droplets in ethanol-treated
Foxo3a/ mouse liver was signiﬁcantly higher than that of
wild-type mice, whereas the number of autophagosomes
was signiﬁcantly decreased in ethanol-treated Foxo3a/of autophagy-related genes, but enhances ethanol-induced apoptosis. A:
ted with 10 multiplicity of infection (MOI) Ad-GFP or Ad-DN-FoxO3a, which
niﬁcation, 20. B: Primary hepatocytes, infected as in A, were treated with
nd RT-qPCR was performed. C: Total cell lysates were subjected to Western
with or without 20 mmol/L CQ, for 6 hours. Total lysates were subjected to
in A, were treated with 80 mmol/L ethanol for 24 hours. Cells were then
antiﬁed. Data are expressed as means  SEM. n Z 3. *P < 0.05, one-way
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Figure 7 Foxo3a/ mice have decreased
expression of autophagy-related genes and
increased liver injury after ethanol administration.
A: Male Foxo3a/ mice and their wild-type lit-
termates were treated with 4.5 g/kg water or
ethanol by gavage for 6 hours. Hepatic mRNA was
isolated, and RT-qPCR was performed. B and C:
Mice were treated as in A, and serum alanine
aminotransferase (ALT) (B) and hepatic tri-
glycerides (TG) (C) were measured. D: Mice were
treated as in A, and total liver lysates were sub-
jected to Western blotting and densitometry anal-
ysis. Data are expressed as means  SEM. nZ 4e6
(AeC); nZ 4 (D). *P < 0.05, one-way analysis of
variance with Scheffé’s post hoc test.
Ni et almouse liver, compared with wild-type mice (Figure 8).
These ﬁndings suggest that the decreased expression of
autophagy-related genes and autophagy in Foxo3a/ mice
may contribute to the increased steatosis and liver injury
after ethanol treatment.
Ethanol Induces Expression of Autophagy-Related
Genes and Autophagic Flux in Primary Human
Hepatocytes
Given that we observed ethanol-induced expression of
autophagy-related genes (Figure 1) and autophagic ﬂux in
primary mouse hepatocytes,9 we next asked whether ethanol1822induces similar effects in human hepatocytes. As with mouse
hepatocytes, ethanol treatment increased the expression of
several autophagy-related genes (Figure 9A), as well as
autophagic ﬂux, as demonstrated by further increased levels
of LC3B-II in the presence of CQ, compared with either
ethanol or CQ treatment alone (Figure 9B).Discussion
The FoxO family of transcription factors regulates multiple
cellular processes (including apoptosis, cell cycle, DNA
damage repair, oxidative stress, and glucose metabolism) andFigure 8 Foxo3a/ mice have decreased
number of hepatic lipid droplets and autophago-
somes after ethanol treatment. Wild-type and
Foxo3a/ mice were treated with ethanol as re-
ported for Figure 7. A: Representative electron
microscopy images are shown. An autophagosome
(boxed) is shown at higher magniﬁcation to the
right. The numbers of lipid droplets (B) and
autophagosomes (C) per 100-mm2 cytosolic areas
were quantiﬁed. Data are expressed as means 
SEM (>20 cell sections). *P < 0.05, one-way
analysis of variance with Scheffé’s post hoc test.
Scale barZ 500 nm. AV, autophagosome; LD, lipid
droplet; M, mitochondria; N, nucleus.
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Figure 9 Ethanol induces autophagy-related gene expression and
autophagic ﬂux in primary human hepatocytes. A: Primary human he-
patocytes were treated with 80 mmol/L ethanol for 3 or 6 hours. mRNA
was isolated, and RT-qPCR was performed. B: Primary human hepatocytes
were treated with 80 mmol/L ethanol in the presence or absence of 20
mmol/L CQ for 6 hours. Total cell lysates were subjected to Western
blotting and densitometry analysis. C: A proposed model for the role of
FoxO3a in ethanol-induced autophagy and liver injury. In ethanol-
exposed hepatocytes, ethanol is metabolized by hepatic enzymes,
which leads to an increase in the NADH/NADþ ratio and to subsequent
inhibition of Sirt1. Ethanol also leads to AKT inhibition, resulting in
FoxO3a dephosphorylation and nuclear retention, which increases the
expression of autophagy-related genes and autophagy. Resveratrol ac-
tivates Sirt1, which leads to FoxO3a deacetylation and enhances
expression of autophagy-related genes. FoxO3a-mediated autophagy pro-
tects against ethanol-induced liver injury, likely by removal of ethanol-
induced accumulation of lipid droplets and damaged mitochondria. Data
are expressed as means  SEM. nZ 4 (A); nZ 3 (B). *P < 0.05, one-way
analysis of variance with Scheffé’s post hoc test.
FoxO3a in Alcohol-Induced Autophagyis highly conserved, from Caenorhabditis elegans to mam-
mals.10,11 The FoxO family has been shown to regulate
autophagy in various systems, including skeletal muscle,12,13
cardiomyocytes,14 kidney,26 liver,27 and cancer cells.28
Depending on the stress conditions, autophagy can be acti-
vated as a cell-survival mechanism, either to provide necessary
nutrients on nutrient deprivation or to remove cellular
damaged or excess organelles and protein aggregates.1,2 We
have previously demonstrated that acute ethanol treatment
induces autophagy as a compensatory mechanism to remove
hepatic lipid droplets and damaged mitochondria to attenuate
ethanol-induced liver steatosis and injury in mice.9,29 How-
ever, it was not known how acute ethanol modulates hepatic
autophagy inmice. Here, we show that acute ethanol treatment
promoted nuclear localization of FoxO3a in both primary
cultured mouse hepatocytes and in mouse liver. In primary
cultured hepatocytes, overexpression of DN-FoxO3a inhibited
ethanol-induced up-regulation of autophagy genes and
enhanced ethanol-induced cell death. Moreover, acute ethanolThe American Journal of Pathology - ajp.amjpathol.orgtreatment led to enhanced steatosis and liver injury in
Foxo3a/ mice, compared with wild-type mice.
It has been suggested that cytosolic FoxO1, particularly
the acetylated form, can bind with Atg7 to promote auto-
phagy in certain cancer cells, independent of its transcrip-
tional activity.28 In contrast, it has been demonstrated that
the transcriptional activities of FoxOs are required for the
induction of autophagy in normal tissues, such as mouse
skeletal muscle,12,13 heart14 and liver.27 In the present study,
FoxO3a-mediated transcription of autophagy-related genes
played a critical role in alcohol-induced autophagy in mouse
liver and primary cultured hepatocytes. This notion is sup-
ported by the following evidence: i) ethanol treatment
increased the nuclear levels of FoxO3a; ii) suppression of
ethanol-mediated expression of autophagy-related genes
by ActD inhibited ethanol-induced autophagy; iii) over-
expression of DN-FoxO3a inhibited ethanol-induced ex-
pression of autophagy-related genes, resulting in reduced
autophagy and increased cell death; and iv) Foxo3a/ mice
exhibited decreased expression of autophagy genes in
ethanol-treated mouse liver, but increased steatosis and liver
injury. Currently, it is not clear why FoxO-mediated tran-
scription of autophagy genes is important for the autophagy
process in normal tissues, but cytosolic FoxOs are important
for autophagy induction in cancer cells. One possible ex-
planation is that activation of Akt is one of the most frequent
alterations observed in human cancer cells, and Akt acti-
vation may lead to increased cytosolic FoxO levels because
of increased Akt-mediated phosphorylation of FoxOs.
The activity of FoxO3a is largely regulated by its multiple
post-translational modiﬁcations, including phosphorylation,
acetylation, ubiquitination, and methylation.10,11 FoxOs are
phosphorylated by the serine/threonine protein kinase Akt
and become sequestered in the cytoplasm, where they are
unable to regulate gene expression.11 Acute ethanol treat-
ment decreased the level of phosphorylated Akt and
FoxO3a. These ﬁndings suggest that acute ethanol-induced
nuclear retention of FoxO3a could be mediated by the Akt
signaling pathway. In contrast to negative regulation of
FoxOs by phosphorylation, the acetylation of FoxOs seems
to be more important for determination of speciﬁcity of
FoxO target genes.15 FoxO acetylation levels are regulated
through acetylation by acetyltransferases (eg, p300/CBP)
and through deacetylation by deacetylases (eg, SIRT1).10,30
SIRT1 deacetylates FoxO3a and modulates its gene tran-
scription and speciﬁcity, which increases the expression of
oxidative stress genes and suppresses the expression of
apoptosis genes in response to oxidative stress.10,15 Ethanol
is reported to decrease SIRT1 expression or activity by
increasing the NADH/NADþ ratio in hepatocytes.31 In
agreement with these reports, we also found that acute
ethanol treatment reduced Sirt1 proteins in mouse liver, but
increased acetylation of FoxO3a. However, ethanol in-
creased the expression of autophagy-related genes in primary
hepatocytes and mouse liver, suggesting that ethanol-
induced nuclear translocation of FoxO3a could be a critical1823
Ni et alfactor, and that this translocation is sufﬁcient to increase
FoxO3a-mediated expression of autophagy-related genes.
The ﬁnding that resveratrol further enhanced ethanol-
induced up-regulation of autophagy genes suggests that
Sirt1-mediated deacetylation of FoxO3a may favor and
promote expression of autophagy-related genes. Further
studies are needed to determine whether the deacetylated
form of FoxO3a has increased binding afﬁnity for the pro-
moters of autophagy-related genes. Nevertheless, our present
ﬁndings collectively indicate that FoxO3a is a major target
in the regulation of ethanol-induced autophagy-related gene
expression and autophagy.
The present results support a novel mechanism for FoxO-
mediated hepatoprotection against acute ethanol adminis-
tration in mice through activation of expression of
autophagy-related genes. This notion is supported by the
observation that overexpression of DN-FoxO3a enhanced
ethanol-induced apoptosis and that Foxo3a/ mice
exhibited exacerbated liver injury and steatosis after acute
ethanol administration. Our results are also consistent with a
recent report that overexpression of Atg14, a target gene of
FoxOs, decreases hepatic triglyceride contents.27 Another
signiﬁcant ﬁnding from our present study was that ethanol
also increased autophagy-related gene expression and
autophagic ﬂux in primary human hepatocytes. However, in
addition to regulating autophagy-related genes, FoxO3a also
regulates expression of genes that have multiple functions,
such as antioxidant and DNA repair genes, which could also
attenuate ethanol-induced liver injury.30
Controversial evidence suggests that autophagy status
could differ between chronic and acute ethanol treatment in
mice.32,33 Although it has been suggested that autophagy
could be decreased in the chronic ethanol feeding model, the
evidence to support this argument is still not clear, because
autophagic ﬂux data in these models are lacking (probably
because the dynamic nature of the autophagic process and of
the constitutive synthesis and turnover of LC3 makes it
difﬁcult to assess autophagic ﬂux in this model). In a recent
study by Lin et al,34 autophagic ﬂux analysis was performed
after the mice were fed a LiebereDeCarli liquid diet; the
results indicated increased autophagic ﬂux after chronic
ethanol feeding, at least at the 4-week time point. These re-
sults were generally consistent with the acute alcohol binge
model. Although more careful autophagic ﬂux assays should
be performed (and with multiple time points) to further
dissect the autophagy process in the chronic ethanol feeding
model, the Lin et al34 study also demonstrated that pharma-
cological promotion of autophagy by rapamycin and carba-
mazepine attenuated ethanol-induced liver injury in this
4-week feeding model. Regardless of the acute or chronic
ethanol treatment, therefore, our ﬁndings, taken together with
those of others, suggest that autophagy modulation could be
one of the ideal approaches to treat alcoholic liver diseases.
Although modulation of Akt or Sirt1 may indirectly enhance
FoxO3a activity, the speciﬁc pharmacological activators for
FoxOs remain to be identiﬁed. Developing speciﬁc FoxO1824activators will be a challenge, but could lead to new ap-
proaches for treatment of alcoholic diseases.
In summary, our data suggest that FoxO3a-mediated auto-
phagy-related gene expression plays a critical role in acute
ethanol-induced autophagy. Genetic loss of FoxO3a enhanced
acute ethanol-induced liver injury and steatosis in mice. The
cellular and molecular events regulating ethanol-induced
FoxO3a-mediated autophagy are summarized in Figure 9C.
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